Compounds > tyrosine

tyrosine and thalidomide

tyrosine has been researched along with thalidomide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dłuzniewski, A; Szydłowska, H1
Anderson, KC; Burger, R; Catley, LP; Chauhan, D; Cheema, P; Hideshima, T; LeBlanc, R; Mitsiades, C; Mitsiades, N; Munshi, NC; Richardson, PG; Shringarpure, R1
Cuzzocrea, S; De Sarro, A; Di Paola, R; Genovese, T; Mazzon, E; Muià, C1
Aloisi, C; Buemi, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Mazzon, E; Mondello, P; Mondello, S1
Cai, Z; Cang, Y; Gao, S; Geng, C; Lin, X; Liu, J; Song, T1

Other Studies

5 other study(ies) available for tyrosine and thalidomide

ArticleYear
On the application of thalidomide as a block of functional groups of proteins in histochemical investigations.
    Folia histochemica et cytochemica, 1978, Volume: 16, Issue:3

    Topics: Animals; Female; Histocytochemistry; Liver; Male; Proteins; Rats; Sulfhydryl Compounds; Thalidomide; Tyrosine

1978
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
    Blood, 2004, Mar-01, Volume: 103, Issue:5

    Topics: Antigens, CD; Antigens, Differentiation; B7-1 Antigen; Blotting, Western; CD28 Antigens; CD3 Complex; CD4 Antigens; CD8 Antigens; Cell Division; CTLA-4 Antigen; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Interleukin-4; Lenalidomide; Lymphocyte Activation; NF-kappa B; Phosphorylation; Precipitin Tests; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thalidomide; Tyrosine; Up-Regulation

2004
Thalidomide treatment reduces colon injury induced by experimental colitis.
    Shock (Augusta, Ga.), 2005, Volume: 23, Issue:6

    Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-1; Mice; Neutrophils; Peroxidase; Poly Adenosine Diphosphate Ribose; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A

2005
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model.
    Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3

    Topics: Animals; Anti-Infective Agents; Blotting, Western; Chlorhexidine; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; I-kappa B Proteins; Immunohistochemistry; Immunosuppressive Agents; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Peroxidase; Poly Adenosine Diphosphate Ribose; Rats; Thalidomide; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A

2009
Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase.
    The Journal of biological chemistry, 2017, 03-03, Volume: 292, Issue:9

    Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Survival; Dexamethasone; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Indoles; Lenalidomide; Multiple Myeloma; Panobinostat; Protein Binding; Proteolysis; Proto-Oncogene Proteins c-abl; Thalidomide; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination

2017